Zobrazeno 241 - 250
of 1 249
pro vyhledávání: ''
Autor:
Katsumasa Kuroi, Seigo Nakamura, Nobuaki Sato, Hiroji Iwata, Masakazu Toi, Futoshi Akiyama, Masafumi Kurosumi, Norikazu Masuda, Hitoshi Tsuda, Shinji Ohno
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Neoadjuvant chemotherapy (NAC) has been accepted as one of the standard treatments for operable breast cancer. However, the term pathologic complete response (pCR) has not been consistently defined. Methods This study was a pooled analysis
Autor:
Matthew J. Ellis, Cynthia X. Ma
Publikováno v:
Breast Cancer Research and Treatment
Neoadjuvant chemotherapy trials have consistently reported lower response rates in hormone receptor-positive (HR+) breast cancer when compared with HR− cases. Preoperative endocrine therapy has therefore become a logical alternative and has gained
Autor:
Naoko Minatani, Norihiko Sengoku, Masaru Kuranami, Hiroshi Nishimiya, Mariko Kikuchi, Hiroshi Katoh, Mina Waraya, Yoshimasa Kosaka, Hirokazu Tanino, Takeo Sato, Masahiko Watanabe, Takumo Enomoto
Publikováno v:
Supportive Care in Cancer
Purpose Dexamethasone, plus a 5-HT3 receptor antagonist and an NK-1 receptor antagonist are recommended for controlling the chemotherapy-induced nausea and vomiting (CINV) of highly emetogenic chemotherapy. Several days of dexamethasone are effective
Autor:
Clemens W.G.M. Löwik, Alexander L. Vahrmeijer, Summer L. Gibbs-Strauss, Rafiou Oketokoun, Gerrit-Jan Liefers, Hak Soo Choi, Susan Troyan, Long Ngo, Joost R. van der Vorst, Alan Stockdale, Yoshitomo Ashitate, J. Sven D. Mieog, Peter J. K. Kuppen, Merlijn Hutteman, Cornelis J.H. van de Velde, Hein Putter, Kevin J. Donohoe, Sylvain Gioux, John V. Frangioni, Vincent T.H.B.M. Smit
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, 18(9), 2483-2491
Annals of Surgical Oncology, 18(9), 2483-2491
Background Near-infrared (NIR) fluorescent sentinel lymph node (SLN) mapping in breast cancer requires optimized imaging systems and lymphatic tracers. Materials and Methods A small, portable version of the FLARE imaging system, termed Mini-FLARE, wa
Publikováno v:
Breast Cancer Research and Treatment
Mammography has been found effective as the primary screening test for breast cancer. We estimated the cumulative probability of false positive screening test results with respect to symptom history reported at screen. A historical prospective cohort
Autor:
Zhaomei Mu, Massimo Cristofanilli, Sandra V. Fernandez, Zaiming Ye, Khoi Chu, Lucy Aburto-Chumpitaz, Jianming Pei, Kimberly M. Boley, Andres J. Klein-Szanto, R. K. Alpaugh, Yu Cao, Sankar Addya, Fredika M. Robertson, Yong Huang, Karthik Devarajan, Kathy Q. Cai
Publikováno v:
Breast Cancer Research and Treatment
Inflammatory breast cancer (IBC) is the most aggressive type of advanced breast cancer characterized by rapid proliferation, early metastatic development and poor prognosis. Since there are few preclinical models of IBC, there is a general lack of un
Autor:
Barbara Radecka, Patricia S. Steeg, Piotr Stępniak, Wojciech Biernat, Sunil Badve, Bogumiła Czartoryska-Arłukowicz, Zorica Tomasevic, Konrad Wojdan, Katarzyna Sosińska-Mielcarek, Renata Duchnowska, George W. Sledge, Jacek Jassem, Stephan Woditschka, Chirayu P. Goswami, Lang Li, Murat Dundar, Yesim Gökmen-Polar
Publikováno v:
Journal of Neuro-Oncology
The overexpression or amplification of the human epidermal growth factor receptor 2 gene (HER2/neu) is associated with high risk of brain metastasis (BM). The identification of patients at highest immediate risk of BM could optimize screening and fac
Autor:
Jian Ma, Lisa A. Carey, Jack P. Hou, Michael L. Gatza, Joel S. Parker, Jeffrey M. Rosen, Xiaping He, Stacy L. Moulder, Charles M. Perou, Grace O. Silva, Paul K. Marcom
Publikováno v:
Breast Cancer Research and Treatment
A large number of DNA copy number alterations (CNAs) exist in human breast cancers, and thus characterizing the most frequent CNAs is key to advancing therapeutics because it is likely that these regions contain breast tumor ‘drivers’ (i.e., canc
Autor:
Anna Glajcar, Joanna Szpor, Katarzyna Ewa Tyrak, Joanna Streb, Agnieszka Pacek, Krzysztof Okoń, Florence Chan, Diana Hodorowicz-Zaniewska
Publikováno v:
Virchows Archiv
Mast cells (MCs) are a part of the innate immune system. The MC functions toward cancer are partially based on the release of chymase and tryptase. However, the MC effect on breast cancer is controversial. The aim of our study was to investigate the
Autor:
Joanna Pikiel, Michelle DeSilvio, Piotr Potemski, Wolfgang Janni, Elżbieta Starosławska, Kathryn Jane Briggs, Christian Caglevic, Etienne Brain, Christos Papadimitriou, Tomasz Sarosiek, Boguslawa Karaszewska, Luca Marini, Christoph Salat
Publikováno v:
Breast Cancer Research and Treatment
Lapatinib is approved in combination with capecitabine for treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) who have progressed on prior trastuzumab in the metastatic setting. Vinorelb